Trials / Completed
CompletedNCT01910935
Effectiveness of Physical Activity Prescription Among Hypertensive Patients of Primary Health Care.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 224 (actual)
- Sponsor
- Coordinación de Investigación en Salud, Mexico · Other Government
- Sex
- All
- Age
- 35 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the effectiveness of a program to increase the physical activity of hypertensive patients using medical services and sports facilities of the Mexican Social Security Institute. The primary hypothesis to be proven is: The intervention will increase the proportion of hypertensive patients complying the physical activity minimum at week to get benefits on health in 20%, compare to patients in control group.
Detailed description
Secondary Hypothesis: The intervention achieved a significant change in the group of hypertensive patients in the following variables: 1. Decreased levels of systolic and diastolic blood pressure, biochemical markers such as total cholesterol, triglycerides and fasting blood glucose and increased HDL cholesterol. 2. Increase muscular endurance and cardio-respiratory capacity according to the categories of risk stratification. 3. Decreased body weight, body mass index and waist circumference.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Physical activity prescription to develop program in group. | Overall the intervention involves a medical reference in primary care (PHC) to hypertensive patients (during routine consultation) to assist the sports facilities of the same Institute, to develop a group program of physical activity which will last 24 weeks. Led by the trained staff in physical activity to patients with chronic diseases. |
Timeline
- Start date
- 2013-07-01
- Primary completion
- 2014-02-01
- Completion
- 2014-04-01
- First posted
- 2013-07-30
- Last updated
- 2014-06-06
Locations
1 site across 1 country: Mexico
Source: ClinicalTrials.gov record NCT01910935. Inclusion in this directory is not an endorsement.